Gaucher’s Disease -- an Underwriting Prospective
نویسنده
چکیده
A detailed description of the types of Gaucher’s is beyond the scope of this paper. Classicall3~ three types are described. Type 2, acute neurologic, is usually fatal in infancy with an average age at death of 18 months.2 Type 3, chronic neurologic, usually presents during childhood with diffuse progressive neurologic symptoms. There is a distinct subgroup whose sole neurological defect is a lateral gaze abnormality. Unfortunately, this subgroup usually has severe, progl2e~ ssive systemic involvement, especially lung and liver.2
منابع مشابه
Gaucher’s Disease, an Unusual Cause of Massive Splenomegaly, a Case Report
Background Gaucher’s Disease (G.D.) is an autosomal recessive disorder resulting from the accumulation of glucocerebrosidase in the cells of macrophage-monocyte system as a result of a deficiency in lysosomal glucocerebrosidase. This enzyme is encoded by a gene on chromosome-1. Here we report a case of Gaucher’s Disease .G.D is rare in Yazd. Case reports We reported a patient that presented...
متن کاملImmunoglobulin Abnormalities in Gaucher ’ s Disease
S ERUM GAMMA GLOBULIN ABNORMALITIES have rarely been reported in Gaucher’s disease. We recently observed a patient with Gaucher’s disease who showed bone marrow plasmacytosis and a homogeneous midgamma “spike” on serum electrophoresis. Less than a year earlier, a similar patient had been reported from this hospital by Tyson, et al.1 Search of the literature disclosed two additional patients wit...
متن کاملAtypical Presentation of a Case of Hemoglobin E Trait with Gaucher’s Disease
Hemoglobin E heterozygotes (Hb AE) are asymptomatic and homozygotes (Hb EE) have a mild microcytic anemia . However, we had a 2 year old female child presenting with moderate pallor necessitating blood transfusions at 6 months to 1 year interval starting from eight months of age. Thorough clinical examination and investigative work-up revealed Hb E trait with Gaucher’s disease. To the best of o...
متن کاملCarles , Thierry Lamireau and Jean - Michel Guillard
We report on the case of a girl with type 1 Gaucher’s disease, treated from age 9 to 15 with highdose enzyme replacement therapy. This treatment did not avert the development of an extensive mutilating hepatic fibrosis warranting a liver transplantation, which was followed by death. In some cases of Gaucher’s disease, alternative strategies such as fractionated or further increased ERT, gene th...
متن کاملStructured settlement annuities, part 1: overview and the underwriting process.
Structured settlement underwriting is the underwriting of medically impaired lives for the purchase of an annuity to fund the settlement. Other than risk assessment, structured settlement (SS) underwriting has little in common with traditional life insurance underwriting. Most noteworthy of these differences is the relative lack of actuarial data on which to base decisions about mortality and t...
متن کامل